Cancer Research AACR Conference on Molecular Diagnostics - 2008  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 27, 1696-1701, September 1, 1967]
© 1967 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by DiPaolo, J. A.
Right arrow Articles by Elis, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by DiPaolo, J. A.
Right arrow Articles by Elis, J.

The Comparison of Teratogenic and Carcinogenic Effects of Some Carbamate Compounds

J. A. DiPaolo and J. Elis1

Etiology, Biology Branch, National Cancer Institute, NIH, Bethesda, Maryland 20014

Ethyl carbamate and a series of related compounds were given in single intraperitoneal doses to pregnant Syrian hamsters on Day 8 of gestation, and fetuses were examined for malformations on Day 13 of gestation. Urethan produced a variety of malformations and growth retardation. Of the compounds modified in the carboethoxy end, n-propyl carbamate was as teratogenic as the ethyl carbamate, and ß-hydroxyethyl carbamate had only borderline effect, while allyl carbamate and n-butyl carbamate were completely negative. Four compounds modified in the cabamyl portion of the molecule were tested. Three of these, ethyl N-methylcarbamate, ethyl N-hydroxycarbamate, and diethylcarbonate, were teratogenic; a fourth, ethyl N,N-dimethylcarbamate was not teratogenic. The ethyl N-hydroxycarbamate was the most potent teratogen tested. Although no qualitative differences were found among the various compounds tested, ethyl N-hydroxycarbamate produced a quantitatively greater number of fetuses with malformed extremities and anophthalmia. The diethylcarbonate was as potent as urethan, the ethyl N-methylcarbamate was more teratogenic than urethan, while the ethyl N,N-dimethylcarbamate was negative. The similarity of abnormalities produced by these teratogens suggests a common mechanism of action for these compounds.

Striking positive correlations were found between the teratogenic effects in hamsters and skin tumor initiation and lung adenomas in mice.

1 Lalor Foundation Fellow. Permanent address: Institute of Pharmacology, Czechoslovak Academy of Sciences, Prague, Czechoslovakia.

Received 12/29/66. Accepted 5/ 2/67.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1967 by the American Association for Cancer Research.